Back

Effect of ethyl icosapent on lipid profile, inflammation, and cardiovascular events in real-world clinical practice: observational registry

24 April 2026 (13:27 - 13:35)
Organised by: Logo
Congress Presentation Part of: Lipids as biomarkers and treatment target Lipids EAPC Premium Access ESC Preventive Cardiology 2026 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Rocio Sanchez Vaca

Puerto Real University Hospital, Puerto Real (Spain)

6 More presentations in this session

Presentation thumbnail
Voting guidelines
Presentation thumbnail
Quiz presentation
Professor V. Vassiliou (Norwich, GB) Doctor S. Gati (London, GB)
Slides Video
Presentation thumbnail
High lipoprotein(a) and LDL-cholesterol goal attainment in cardiac rehabilitation
Mr J. Kafol (Ljubljana, SI)
Abstract Slides Video
Presentation thumbnail
Sex-specific relationships between genetically proxied lipid traits and cardiovascular disease: a Mendelian randomisation approach
Assistant Professor L. Tschiderer (Innsbruck, AT)
Abstract Slides Video
Presentation thumbnail
Remnant cholesterol variability and the risk of all-cause and cardiovascular mortality: findings from a prospective community-based cohort study
Doctor A. Abdi (Tehran, IR)
Abstract Slides Video

Access the full session

Session thumbnail
Lipids as biomarkers and treatment target
Video

The Event

Event poster

ESC Preventive Cardiology 2026

24 April 2026 13:27 CET
You may be interested in
thumbnail
Congress Session
Improving the management of patients with atherosclerotic cardiovascular disease: the evolving role of icosapent ethyl
thumbnail
Congress Session
Improving pharmacotherapy in primary prevention
thumbnail
Congress Session
Refining efficacy and safety of lipid-lowering pharmacotherapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources